From: Recommendations for clinical interpretation of variants found in non-coding regions of the genome
Region | Mechanism | Example (variant/gene) | Example (disease) | ClinVar Var ID | Reference | VEP categories | In silico tools to predict effect |
---|---|---|---|---|---|---|---|
Promoter | Altering transcription factor binding | GATA1:−113A>G | Hereditary persistence of foetal haemoglobin |  | 1 | Upstream gene variant / regulatory region / TF binding site | TF binding site disruption prediction tools e.g. motifbreakR / SEMpl / QBiC-Pred |
Promoter | Altering transcription | CHM c.-98C>A, c.-98C>T | Choroideremia | Â | 2 | Â | |
Promoter/5′UTR | Altering methylation patterns | BRCA1:c.-107A>T | Breast and ovarian cancer |  | 3 | Upstream gene variant / 5 prime UTR variant |  |
5′UTR | Creating upstream start site (uAUG) | NF1:c.-272G>A | Neurofibromatosis type 1 | 1013130 | 4 | 5 prime UTR variant | e.g. UTRannotator |
5′UTR | Perturbing upstream open reading frames | NF2:−66-65insT | Neurofibromatosis type 2 |  | 5 | e.g. UTRannotator | |
5′UTR | Disrupting internal ribosome entry sites (IRES) | GJB1:c.-103C>T | Charcot-Marie-Tooth disease | 217166 | 6 | e.g. IRESpy / IRESfinder / IRESite | |
5′UTR | Disrupting splicing | SHOX:c.-19G>A | SHOX haploinsufficiency | 933226 | 7 | Splicing prediction tools e.g. SpliceAI | |
5′UTR | Altering Kozak consensus of start site | GATA4:c.-6G>C | Atrial septal defect |  | 8 | e.g. utR.annotation | |
5′UTR | N-terminal transcript elongation | MEF2C:c.−8C>T | Developmental disorder |  | 9 | e.g. UTRannotator | |
Intron | Disrupting canonical splice sites | MYBPC3:c.3490+1G>A | Hypertrophic cardiomyopathy | 42715 | 10 | Splice donor variant / splice acceptor variant / splice region variant / splice_donor_5th_base_variant / splice_polypyrimidine_tract_variant | Splicing prediction tools e.g. SpliceAI |
Intron | Disrupting splicing branch point | HNF4A:c.264-21A>G | Maturity-onset diabetes of the young | Â | 11 | Intron variant | Splicing prediction tools e.g. SpliceAI |
Intron | Pseudo-exon activation | DMD: c.7310-19A>G | Muscular dystrophy | Â | 12 | Splicing prediction tools e.g. SpliceAI | |
Intron | Poison-exon inclusion | SCN1A:c.4002+2165C>T | Dravet Syndrome | Â | 13 | Splicing prediction tools e.g. SpliceAI | |
Intron | Branchpoint mutation | BBS1:c.592-21A>T | Retinitis pigmentosa | Â | 14 | Splicing prediction tools e.g. SpliceAI | |
Intron | Indels & spacing of splicing motifs | DOK7:c.54+8_54+17del | Â | Â | 15 | Splicing prediction tools e.g. SpliceAI | |
Intron | Cryptic exon | VHL: c.3401770T.C | Erythrocytosis | Â | 16 | Â | Â |
3′UTR | Disrupting polyA signal motif | NAA10:c.a43A>G | Microphthalmia | 617463 | 17 | 3 prime UTR variant | PolyA signal motif prediction tools e.g. Omni-PolyA |
3′UTR | Disrupting miRNA interactions | REEP1 | Hereditary spastic paraplegia |  | 18 | miRNA binding site prediction e.g. miRTarBase | |
3′UTR | Disrupting splicing | LHFPL5:c.a16+1G>A | Hearing impairment |  | 19 | Splicing prediction tools e.g. SpliceAI | |
CRE | Altering transcription factor binding | chr7:155754267:C>T; NCBI build 36.3 | Holoprosencephaly | Â | 20 | Upstream gene variant / downstream gene variant / regulatory region variant / TF binding site variant / intergenic variant / TFBS ablation / TFBS amplification / regulatory region ablation / regulatory region amplification | TF binding site disruption prediction tools e.g. motifbreakR / SEMpl / QBiC-Pred |
CRE | Abolishing enhancer activity | PTF1A - 6 variants | Isolated pancreatic agenesis | Â | 21 | Â | |
CRE | Disrupting enhancer activity | SOX9 - deletion (chr17:67,628,756–67,634,155) | Pierre Robin sequence |  | 22 |  | |
Intergenic | Creating new regulatory element | chr16:209,709 T>C | α-thalassaemia |  | 23 | Intergenic variant / upstream gene variant / downstream gene variant |  |
miRNA | Disrupting seed region | miR-204:n.37C>T | Retinal dystrophy | Â | 24 | non-coding transcript exon variant / non-coding transcript variant / mature_miRNA_variant | Â |
snRNA | Altering structure | RNU12 | Cerebellar ataxia | Â | 25 | Non-coding transcript exon variant / non-coding transcript variant | Â |
snRNA | Abnormal splicing, accumulation of minor intron retained transcripts | RNU4ATAC | Roifman Syndrome | Â | 26 | Splicing prediction tools e.g. SpliceAI | |
snRNA | Affecting expression, processing and protein binding | SNORD118 | Cerebral microangiopathy leukoencephalopathy | Â | 27 | Â | Â |
TAD boundary | Disrupting chromatin looping leading to enhancer loss or adoption | WNT6/IHH/EPHA4/PAX3 locus | Limb phenotypes | Â | 28 | Intergenic variant | Â |